acetylcarnitine has been researched along with zk-219477 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baurain, JF; Berton-Rigaud, D; Campone, M; de Bont, N; Fabbro, M; Joly-Lobbedez, F; Pautier, P; Pinkert, J; Rolland, F; Schmelter, T; Stenzl, A; van Dijk, M | 1 |
| Burotto, M; Fojo, AT | 1 |
1 trial(s) available for acetylcarnitine and zk-219477
| Article | Year |
|---|---|
A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy.
Topics: Acetylcarnitine; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzothiazoles; Double-Blind Method; Epothilones; Female; Humans; Male; Middle Aged; Ovarian Neoplasms; Peripheral Nervous System Diseases; Prospective Studies; Prostatic Neoplasms, Castration-Resistant | 2013 |
1 other study(ies) available for acetylcarnitine and zk-219477
| Article | Year |
|---|---|
Acetyl-L-carnitine and prevention of chemotherapy-induced peripheral neuropathy: can anything work?
Topics: Acetylcarnitine; Benzothiazoles; Epothilones; Female; Humans; Male; Peripheral Nervous System Diseases | 2013 |